Business Context and Reporting Period
On June 7, 2008, Willis Group Holdings Limited (Willis) entered into a definitive Agreement and Plan of Merger with Hilb Rogal & Hobbs Company (HRH). The transaction involves HRH merging with a wholly-owned subsidiary of Willis, with the merger anticipated to close in the fourth quarter of 2008.
Key Financial Metrics and Transaction Terms
- Merger Consideration: HRH shareholders will receive cash and/or Willis common stock with a target value of $46.00 per share.
- Consideration Structure: The deal utilizes a collar mechanism. The cash component is fixed at $23.00 per share. The stock component is valued at $23.00 per share if Willis stock trades between $31.46 and $40.04 during the ten-day period ending two days prior to closing. Outside this range, the exchange ratio is fixed, potentially altering the implied value.
- Issuance Cap: The number of Willis shares issued is limited to no more than 19.9% of Willis common stock outstanding immediately prior to the merger.
- Termination Fee: HRH may be required to pay Willis a termination fee of $74 million under specified circumstances.
- Stock Options: Outstanding HRH stock options and awards will vest and convert to Willis stock options on substantially similar terms.
Material Changes and Conditions
This filing represents a material change in corporate structure through a proposed acquisition. The transaction is subject to several conditions, including:
- Approval by HRH shareholders.
- Receipt of required governmental and regulatory approvals.
- Expiration of applicable waiting periods.
- Accuracy of representations and warranties.
- Receipt of opinions that the merger qualifies as a tax-free reorganization.
The filing does not provide specific revenue, profit, or cash flow metrics for the reporting period, as it is a current report regarding a definitive agreement rather than a periodic financial report.
Outlook, Risks, and Management Commentary
Management anticipates the merger will close in the fourth quarter of 2008. The filing includes forward-looking statements regarding potential benefits, including cost savings and synergies, which are subject to significant risks.
- Integration Risks: The integration of HRH with Willis may not be successful, may be delayed, or may be more costly than expected.
- Regulatory Risks: The transaction may not be consummated if regulatory approvals are denied or delayed.
- Market Risks: General industry and economic conditions could affect the expected financial performance of the combined company.
- Termination Rights: Either party may terminate the agreement under specific conditions, such as failure to obtain shareholder approval, denial of regulatory approvals, or a breach of the agreement.
Investor Verification Checklist
- Verify the final form of consideration (cash vs. stock) based on Willis stock price at closing.
- Confirm the receipt of all necessary regulatory and shareholder approvals.
- Review the upcoming Form S-4 registration statement and proxy statement for detailed financial data and risk factors.
- Monitor the 19.9% issuance cap and potential proration mechanisms if shareholder elections exceed limits.
- Assess the likelihood of the $74 million termination fee being triggered if the deal fails.